ASC Oncology GmbH

ASC Oncology was founded in 2019 by nine leading scientists in the fields of pathology, tumor biology, biochemistry, biotechnology and molecular biology to address one of the most important challenges in modern oncology: Providing patients with the right therapy at the right time. ASC Oncology offers patients and their treating physicians Reverse Clinical Engineering®, a cutting-edge technology designed to bridge the gap between current cancer research and clinical practice.

Our Vision: Our goal is to establish precision medicine as the standard in modern cancer therapy. Personalized therapy plans must become the rule. Among others, patients should receive treatment that is optimally tailored to them by use of the Reverse Clinical Engineering® test procedure. It is our common goal, and that of society and medicine, that no patient should die prematurely and avoidably from cancer. We are committed to this ‚Vision Zero‘ with our work. The focus is always on the patient, who is informed and involved in the treatment decision on an equal footing.